Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.
  • BioLine Rx (NASDAQ:BLRX) shares increased by 12.29% to $1.37. The market value of their outstanding shares is at $65.3 million.
  • Cabaletta Bio (NASDAQ:CABA) stock increased by 10.14% to $1.52. The market value of their outstanding shares is at $44.0 million.
  • Jasper Therapeutics (NASDAQ:JSPR) shares increased by 8.52% to $3.31. The market value of their outstanding shares is at $125.3 million.
  • Chembio Diagnostics (NASDAQ:CEMI) stock moved upwards by 7.69% to $0.62. The company's market cap stands at $18.7 million.
  • Allena Pharma (NASDAQ:ALNA) stock rose 7.62% to $0.17. The market value of their outstanding shares is at $15.7 million.

Losers

  • First Wave BioPharma (NASDAQ:FWBI) shares declined by 34.0% to $0.41 during Friday's after-market session. This security traded at a volume of 640.9K shares come close, making up 78.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
  • NeoGenomics (NASDAQ:NEO) stock fell 9.32% to $8.57. The company's market cap stands at $1.0 billion. The company's, Q1 earnings came out 2 days ago.
  • Aclarion (NASDAQ:ACON) shares fell 7.73% to $1.91. The company's market cap stands at $14.9 million.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares decreased by 5.68% to $1.33. The market value of their outstanding shares is at $58.0 million.
  • Syndax Pharmaceuticals (NASDAQ:SNDX) stock fell 5.67% to $15.82. The company's market cap stands at $870.3 million.
  • Midatech Pharma (NASDAQ:MTP) stock fell 4.77% to $0.62. The company's market cap stands at $12.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.